Marchesi, Julian R.

Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial

Allegretti, J. R., Kassam, Z., Carrellas, M., Mullish, B. H., Marchesi, J. R., Pechlivanis, A., Smith, M., Gerardin, Y., Timberlake, S., Pratt, D. S., et al. (2019) · American Journal of Gastroenterology

Liver Diseases and ImmunityGut microbiota and health

Cited by 234

Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study

van Woerden, H. C., Gregory, C., Brown, R., Marchesi, J. R., Hoogendoorn, B., & Matthews, I. P. (2013) · BMC Infectious Diseases

Asthma and respiratory diseasesIndoor Air Quality and Microbial Exposure

Cited by 177

Microbiomic analysis of the bifidobacterial population in the human distal gut

Turroni, F., Marchesi, J. R., Foroni, E., Gueimonde, M., Shanahan, F., Margolles, A., van Sinderen, D., & Ventura, M. (2009) · The ISME Journal

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 137

Antibiotic therapy and outcome from immune-checkpoint inhibitors

Pinato, D. J., Gramenitskaya, D., Altmann, D. M., Boyton, R. J., Mullish, B. H., Marchesi, J. R., & Bower, M. (2019) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 116

Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites

Yip, A. Y. G., King, O. G., Omelchenko, O., Kurkimat, S., Horrocks, V., Mostyn, P., Danckert, N., Ghani, R., Satta, G., Jauneikaite, E., et al. (2023) · Nature Communications

Gut microbiota and healthAntibiotic Resistance in Bacteria

Cited by 91

A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease

Payne, T., Appleby, M., Buckley, E., van Gelder, L. M. A., Mullish, B. H., Sassani, M., Dunning, M. J., Hernandez, D., Scholz, S. W., McNeill, A., et al. (2023) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 76

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

Martinez-Gili, L., Pechlivanis, A., McDonald, J. A. K., Begum, S., Badrock, J., Dyson, J. K., Jones, R., Hirschfield, G., Ryder, S. D., Sandford, R., et al. (2023) · Gut Microbes

Liver Diseases and ImmunityGut microbiota and health

Cited by 32

Neoadjuvant immunotherapy with ipilimumab plus nivolumab and radiologically and pathologically quantifiable responses through modulation of the tumour microenvironment in resectable hepatocellular carcinoma

D'Alessio, A., Pai, M., Spalding, D., Goldin, R. D., Scheiner, B., Korolewicz, J., Fulgenzi, C. A. M., Ward, C., Yip, V., Slater, S., et al. (2023) · Journal of Clinical Oncology

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 17